SignatureFD’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2.47K	Buy	+165	New	+$2.47K	﹤0.01%	2802
2025 Q1	–	Sell	-68	Closed	-$1.58K	–	3428
2024 Q4	$1.58K	Buy	+68	New	+$1.58K	﹤0.01%	2919